Danaher Corporation $DHR is Wormser Freres Gestion’s 9th Largest Position

Wormser Freres Gestion increased its position in Danaher Corporation (NYSE:DHR) by 586.7% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 37,860 shares of the conglomerate’s stock after acquiring an additional 32,347 shares during the quarter. Danaher comprises 4.9% of Wormser Freres Gestion’s investment portfolio, making the stock its 9th largest holding. Wormser Freres Gestion’s holdings in Danaher were worth $8,670,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Elevated Capital Advisors LLC purchased a new stake in Danaher in the 4th quarter worth about $26,000. JPL Wealth Management LLC purchased a new stake in Danaher in the 3rd quarter worth about $25,000. WFA of San Diego LLC purchased a new stake in Danaher in the 2nd quarter worth about $26,000. ANTIPODES PARTNERS Ltd purchased a new stake in Danaher in the 3rd quarter worth about $27,000. Finally, MidAtlantic Capital Management Inc. purchased a new stake in Danaher in the 4th quarter worth about $33,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 1.2%

DHR stock opened at $182.73 on Friday. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $129.33 billion, a PE ratio of 35.34, a PEG ratio of 2.44 and a beta of 0.81. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The stock has a 50-day simple moving average of $182.11 and a two-hundred day simple moving average of $207.48.

Danaher (NYSE:DHR) last posted its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. The business had revenue of $5.95 billion during the quarter, compared to analyst estimates of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The company’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.88 EPS. On average, equities analysts predict that Danaher Corporation will post 8.43 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. Danaher’s payout ratio is presently 30.95%.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on DHR shares. Rothschild & Co Redburn set a $205.00 price objective on Danaher in a report on Friday, April 17th. TD Cowen decreased their price objective on Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Wells Fargo & Company decreased their price objective on Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a report on Wednesday, April 22nd. Royal Bank Of Canada assumed coverage on Danaher in a report on Thursday, May 14th. They set an “outperform” rating and a $200.00 target price for the company. Finally, Barclays reduced their target price on Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. Twenty investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $238.24.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.